0000912282-23-000523.txt : 20231128 0000912282-23-000523.hdr.sgml : 20231128 20231128115140 ACCESSION NUMBER: 0000912282-23-000523 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231121 FILED AS OF DATE: 20231128 DATE AS OF CHANGE: 20231128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VITA NICHOLAS CENTRAL INDEX KEY: 0001907623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56294 FILM NUMBER: 231443311 MAIL ADDRESS: STREET 1: C/O COLUMBIA CARE INC. STREET 2: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cannabist Co Holdings Inc. CENTRAL INDEX KEY: 0001776738 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 981488978 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125543424 MAIL ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Columbia Care Inc. DATE OF NAME CHANGE: 20190514 4 1 form4.xml X0508 4 2023-11-21 0001776738 Cannabist Co Holdings Inc. CBSTF 0001907623 VITA NICHOLAS C/O THE CANNABIST COMPANY HOLDINGS INC. 680 FIFTH AVENUE, 24TH FLOOR NEW YORK NY 10019 true true Chief Executive Officer false Common Shares 2023-11-21 4 S 0 100000 0.3468 D 21327075 I Held by Vita Holdings LLC Common Shares 2023-11-22 4 S 0 50000 0.3607 D 21277075 I Held by Vita Holdings LLC Common Shares 2023-11-27 4 S 0 50000 0.352 D 21227075 I Held by Vita Holdings LLC Common Shares 2023-11-27 4 S 0 50000 0.3557 D 21177075 I Held by Vita Holdings LLC Common Shares 618950 D The sales price reported above was converted from the Canadian sales price of C$0.475 using an exchange rate of C$1.3698 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.495 using an exchange rate of C$1.3723 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.48 using an exchange rate of C$1.3635 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.485 using an exchange rate of C$1.3635 = US$1.00. Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes. /s/ Nicholas Vita 2023-11-28